DARPA eyes optogenetics; Metactive raises $2M Series A;

@FierceMedDev: J&J readies to rid itself of Cordis--for as much as $2B to Cardinal Health. More | Follow @FierceMedDev

@VarunSaxena2: Reg. standards may be for NGS materials, methods & performance. Specific for each area (oncology, germline mutations etc) #PrecisionMedicine. | Follow @VarunSaxena2

@EmilyWFierce: Bayer feels sting of mixed decision from NICE for Eylea's use in diabetics. Article | Follow @EmilyWFierce

> DARPA is reportedly working on an optogenetics project to restore sight to the blind via genetic manipulation at the level of the optical neurons. Story

> Metactive has raised a $2 million Series A round to develop embolization devices to treat peripheral vascular and neurovascular diseases as alternatives to coils and stents. This brings the total raised by the company to $7 million. More

> The World Health Organization has approve the first rapid Ebola test, which is from Corgenix ($CONX). Story

> Cantel Medical ($CMN) has acquired MRLB for $10 million in cash to add its DentaPure products to its infection control and prevention portfolio. DentaPure is a water filtration system used by dentists. Release

Biotech News

@FierceBiotech: Merck KGaA carves into MS R&D after a string of setbacks. Story | Follow @FierceBiotech

@JohnCFierce: $LLY, that wunderkind of drug R&D, delays peglispro after all and Tim Anderson sounds taps. Release | Follow @JohnCFierce

@DamianFierce: Big day for Tularik expats, particularly the ones at Flexus and NGM. Story | Report | Follow @DamianFierce

> Celldex jumps after gaining an FDA 'breakthrough.' More

> Bristol-Myers bags IDO immunotherapy in $1.25B buyout of fledgling Flexus. Article

Pharma News

@FiercePharma: Brain cancer therapy pioneered in dogs wins NCI grant for human development. More | Follow @FiercePharma

@CarlyHFierce: Valeant To Acquire Salix Pharmaceuticals For $158.00 Per Share In Cash. Release | Follow @CarlyHFierce

> Bayer reportedly close to diabetes device sale worth up to $2.3B. Story

> New Sanofi chief's €4M signing bonus 'incomprehensible' to French officials. News

Biotech IT News

> AstraZeneca picks Labguru to improve collaborations with academia. More

> FDA puts cloud storage and Google-esque search tools on precision medicine road map. Story

> Big Data digging yields unprecedented road map of the epigenome. Article

> BGI investor: It is the database they are building that will make them formidable. Report

> Transcriptic snags $8.5M to add capabilities at robot-run lab. News

CRO News

> LabCorp seals its $6B deal for Covance. Article

> After a $300M IPO, PRA forecasts a big 2015. More

> Theorem partners up for patient testing. Report

> Parexel stretches out its site network to speed up enrollment. Story

> WuXi borrows $165M to bankroll more M&A. Item

Animal Health News

> Jaguar posts positive trial results on lead prescription drug for dogs. Item

> Patterson misses on sales and earnings but reaffirms fiscal 2015 guidance. Report

> Australia's Integrated Animal Health to open offices in U.S. Story

> Brain cancer therapy pioneered in dogs wins NCI grant for human development. News

> Dogs get pulled into the medical marijuana debate. Article

Suggested Articles

Thermo Fisher Scientific has begun early talks to take over Dutch diagnostics maker Qiagen, according to reports.

Atomwise and Velocity Pharmaceutical Development co-founded a company to carry AI-derived drugs through preclinical testing and into takeout deals.

Sera Prognostics has raised $36 million in funding to help commercialize its blood test for assessing the risk of premature births.